Clinical Trial Update: Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating hydralazine/isosorbide dinitrate versus placebo in African patients admitted with acute heart failure; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Ventricular Dysfunction

Drugs mentioned

• BIDIL (Hydralazine hydrochloride and isosorbide dinitrate)

Snippet

Sponsor: University of Cape Town | Conditions: Acute Heart Failure, Left Ventricular Dysfunction | Phase 3 | Status: UNKNOWN